Technical Analysis for NEO - NeoGenomics, Inc.

Grade Last Price % Change Price Change
grade A 23.19 0.87% 0.20
NEO closed up 0.87 percent on Monday, May 20, 2019, on 51 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical NEO trend table...

Date Alert Name Type % Chg
Stochastic Sell Signal Bearish 0.00%
Overbought Stochastic Strength 0.00%
Outside Day Range Expansion 0.87%
Overbought Stochastic Strength 0.87%
NR7 Range Contraction -1.61%
NR7-2 Range Contraction -1.61%
Stochastic Reached Overbought Strength -1.61%
Overbought Stochastic Strength -1.61%
Up 3 Days in a Row Strength -1.61%
NR7 Range Contraction 0.35%

Older signals for NEO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
NeoGenomics, Inc., together with its subsidiary, NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company performs analyses for hematopoietic cancers, such as leukemia and lymphoma; and solid tumor cancers comprising breast, lung, colon, and bladder cancer. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry testing services to identify cell proteins in a tissue section; and molecular testing services that focus on the analysis of DNA and RNA, as well as on the structure and function of genes at the molecular level. The company's trademarks include NeoFISH, NeoFlow, NeoSITE, NeoArray, NeoType, and MelanoSITE. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
Cancer Biology Diseases Genetics Lymphoma Medical Tests Leukemia Anatomical Pathology Laboratory Techniques Bladder Cancer Solid Tumor Cancers Hybridization Cytogenetics Fluorescence In Situ Hybridization
Is NEO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 23.85
52 Week Low 11.05
Average Volume 739,335
200-Day Moving Average 16.5847
50-Day Moving Average 20.9402
20-Day Moving Average 22.0505
10-Day Moving Average 22.759
Average True Range 0.9318
ADX 18.24
+DI 24.3459
-DI 20.4491
Chandelier Exit (Long, 3 ATRs ) 21.0546
Chandelier Exit (Short, 3 ATRs ) 21.6954
Upper Bollinger Band 24.4125
Lower Bollinger Band 19.6885
Percent B (%b) 0.74
BandWidth 21.42355
MACD Line 0.7128
MACD Signal Line 0.6675
MACD Histogram 0.0453
Fundamentals Value
Market Cap 1.84 Billion
Num Shares 79.4 Million
EPS -0.33
Price-to-Earnings (P/E) Ratio -70.27
Price-to-Sales 2.72
Price-to-Book 4.01
PEG Ratio 3.28
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.90
Resistance 3 (R3) 24.75 24.02 24.62
Resistance 2 (R2) 24.02 23.59 24.10 24.52
Resistance 1 (R1) 23.61 23.32 23.82 23.76 24.42
Pivot Point 22.88 22.88 22.99 22.96 22.88
Support 1 (S1) 22.47 22.45 22.68 22.62 21.96
Support 2 (S2) 21.74 22.18 21.82 21.86
Support 3 (S3) 21.33 21.74 21.77
Support 4 (S4) 21.48